PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice

por Xi, Zheng-Xiong, Hempel, Briana, Crissman, Madeline, Pari, Sruti, Klein, Benjamin, Bi, Guo-Hua, Alton, Hannah
Publicado 2023

Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research

por Galaj, Ewa, Hempel, Briana, Moore, Allamar, Klein, Benjamin, Bi, Guo-Hua, Gardner, Eliot L., Seltzman, Herbert H., Xi, Zheng-Xiong
Publicado 2022

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

por He, Xiang-Hu, Galaj, Ewa, Bi, Guo-Hua, He, Yi, Hempel, Briana, Wang, Yan-Lin, Gardner, Eliot L., Xi, Zheng-Xiong
Publicado 2021

A highly D(3)R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D(3)R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use di...

por Galaj, Ewa, Bi, Guo-Hua, Klein, Benjamin, Hempel, Briana, Shaik, Anver Basha, Gogarnoiu, Emma S., Friedman, Jacob, Lam, Jenny, Rais, Rana, Reed, John F., Bloom, Shelley H., Swanson, Tracy L., Schmachtenberg, Jennifer L., Eshleman, Amy J., Janowsky, Aaron, Xi, Zheng-Xiong, Newman, Amy Hauck
Publicado 2022